129 related articles for article (PubMed ID: 8801526)
41. Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse.
Raffa RB; Martinez RP; Porreca F
Eur J Pharmacol; 1992 Jun; 216(3):453-6. PubMed ID: 1330585
[TBL] [Abstract][Full Text] [Related]
42. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats.
Ren K; Williams GM; Hylden JL; Ruda MA; Dubner R
Eur J Pharmacol; 1992 Aug; 219(2):235-43. PubMed ID: 1358641
[TBL] [Abstract][Full Text] [Related]
43. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes.
Spanagel R; Almeida OF; Shippenberg TS
Eur J Pharmacol; 1994 Oct; 264(2):157-62. PubMed ID: 7851478
[TBL] [Abstract][Full Text] [Related]
44. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
[TBL] [Abstract][Full Text] [Related]
45. Differential modulation by muscimol and baclofen on antinociception induced by morphine, beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Kim YH; Choi YS; Yoo JS; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):614-9. PubMed ID: 9053732
[TBL] [Abstract][Full Text] [Related]
46. Non-NMDA receptor antagonist attenuates antinociception induced by morphine but not beta-endorphin, D-Pen2-D-Pen5-enkephalin, and U50, 488H administered intracerebroventricularly in mice.
Suh HW; Choi YS; Yoo JS; Song DK; Kim YH; Tseng LF
Neuropeptides; 1995 Feb; 28(2):125-9. PubMed ID: 7746356
[TBL] [Abstract][Full Text] [Related]
47. Variations of motor activity following intraventricular (D-Pen2, D-Pen5)-enkephalin administration: interaction with acute uncontrollable foot-shock in mice.
Mendella PD; Zacharko RM
Pharmacol Biochem Behav; 1996 Apr; 53(4):877-83. PubMed ID: 8801592
[TBL] [Abstract][Full Text] [Related]
48. Different effects of NMDA/group I metabotropic glutamate receptor agents in delta- and mu-opioid receptor agonist-induced supraspinal antinociception.
Suzuki T; Aoki T; Ohnishi O; Nagase H; Narita M
Eur J Pharmacol; 2000 May; 396(1):23-8. PubMed ID: 10822049
[TBL] [Abstract][Full Text] [Related]
49. Effects of morphine-3-glucuronide on the antinociceptive activity of peptide and nonpeptide opioid receptor agonists in mice.
Bian JT; Bhargava HN
Peptides; 1996; 17(8):1415-9. PubMed ID: 8971939
[TBL] [Abstract][Full Text] [Related]
50. Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features.
Haaseth RC; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
Int J Pept Protein Res; 1990 Aug; 36(2):139-46. PubMed ID: 2177042
[TBL] [Abstract][Full Text] [Related]
51. [L-Ala3]DPDPE: a new enkephalin analog with a unique opioid receptor activity profile. Further evidence of delta-opioid receptor multiplicity.
Haaseth RC; Horan PJ; Bilsky EJ; Davis P; Zalewska T; Slaninova J; Yamamura HI; Weber SJ; Davis TP; Porreca F
J Med Chem; 1994 May; 37(11):1572-7. PubMed ID: 8201592
[TBL] [Abstract][Full Text] [Related]
52. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
53. Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices.
Suarez-Roca H; Maixner W
Eur J Pharmacol; 1992 Dec; 229(1):1-7. PubMed ID: 1282103
[TBL] [Abstract][Full Text] [Related]
54. N-Methyl-D-aspartate attenuates opioid receptor-mediated G protein activation and this process involves protein kinase C.
Fan GH; Zhao J; Wu YL; Lou LG; Zhang Z; Jing Q; Ma L; Pei G
Mol Pharmacol; 1998 Apr; 53(4):684-90. PubMed ID: 9547359
[TBL] [Abstract][Full Text] [Related]
55. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
56. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
Life Sci; 1995; 57(2):155-68. PubMed ID: 7603296
[TBL] [Abstract][Full Text] [Related]
57. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered beta-endorphin and morphine or DPDPE in mice.
Suh HH; Tseng LF
Life Sci; 1990; 46(11):759-65. PubMed ID: 2157119
[TBL] [Abstract][Full Text] [Related]
58. Electrophysiological studies on the postnatal development of the spinal antinociceptive effects of the delta opioid receptor agonist DPDPE in the rat.
Rahman W; Dickenson AH
Br J Pharmacol; 1999 Mar; 126(5):1115-22. PubMed ID: 10204998
[TBL] [Abstract][Full Text] [Related]
59. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
Bhargava HN; Thorat SN
Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
[TBL] [Abstract][Full Text] [Related]
60. The effects of dopamine D1 and D2 receptor antagonists on the rewarding effects of delta 1 and delta 2 opioid receptor agonists in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Nagase H
Psychopharmacology (Berl); 1996 Apr; 124(3):211-8. PubMed ID: 8740041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
